Godshall Douglas Evan's Form 4 filing
Shockwave Medical, Inc. (SWAV) · filed Nov 17, 2023
- Accession no.
- 0001209191-23-055916
- Filed
- Nov 17, 2023
- Trade date
- Nov 15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $870.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Godshall Douglas EvanCIK 0001404227 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Common Stock | SSaleDisposed | −1,100 | $171.56 | −$188,716 | 139,957 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −900 | $172.82 | −$155,538 | 139,057 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −500 | $173.93 | −$86,965 | 138,557 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −1,186 | $175.11 | −$207,680.46 | 137,371 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −914 | $175.82 | −$160,699.48 | 136,457 | Direct | |
| Nov 15, 2023 | Common Stock | SSaleDisposed | −400 | $177.02 | −$70,808 | 136,057 | Direct | |
| Nov 15, 2023 | Common Stock | MOption exerciseAcquired | +5,000 | $3.42 | +$17,100 | 141,057 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 329,799 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.